PINK1 affects mitochondrial oxidative phosphorylation by regulating MFN2 to alleviate diabetic kidney disease

Xiaoyan Pei1, Jie Liu1, Yu Wei1

  • 1Department of Endocrinology, the First Affiliated Hospital of Bengbu Medical University, Bengbu, Anhui 233004, PR China.

Abstract

Insights

Mitofusin 2 (MFN2) protects against diabetic kidney disease (DKD) by improving mitochondrial function and reducing inflammation. PTEN-induced kinase 1 (PINK1) regulates MFN2, offering a potential therapeutic target for DKD.

Area of Science:

  • Nephrology
  • Molecular Biology
  • Mitochondrial Biology

Background:

  • Diabetic kidney disease (DKD) is a major complication of diabetes.
  • The role of Mitofusin 2 (MFN2) in DKD pathogenesis is not fully understood.
  • This study investigates MFN2's role and molecular pathways in advanced DKD.

Purpose of the Study:

  • To explore the role of MFN2 in advanced diabetic kidney disease.
  • To elucidate the molecular mechanisms underlying MFN2's involvement in DKD.
  • To identify potential therapeutic targets for DKD.

Main Methods:

  • MFN2 was manipulated in high glucose-treated HK2 cells and db/db mouse models.
  • Evaluated cell proliferation, apoptosis, mitochondrial oxidative phosphorylation, kidney morphology, and fibrosis.
  • Assessed macrophage polarization and inflammatory factors (TNF-α, IL-6, IL-1β).
  • Utilized the STRING database to explore upstream regulatory mechanisms.

Main Results:

  • MFN2 expression was downregulated in high glucose conditions.
  • MFN2 overexpression enhanced HK2 cell proliferation, improved mitochondrial oxidative phosphorylation, and reduced apoptosis.
  • MFN2 overexpression protected against DKD-induced nephropathy and fibrosis in db/db mice.
  • MFN2 modulated macrophage polarization and inflammatory factors via mitochondrial oxidative phosphorylation.
  • PTEN-induced kinase 1 (PINK1) was identified as a regulator of MFN2 in DKD.

Conclusions:

  • MFN2 plays a protective role in DKD by maintaining mitochondrial function.
  • PINK1 regulates MFN2's function in DKD.
  • MFN2, regulated by PINK1, represents a potential therapeutic target for diabetic kidney disease.